Zobrazeno 1 - 10
of 549
pro vyhledávání: '"Mercy A. Thomas"'
Mercy Evanescent: Thomas of Celano’s Rewrite of the Encounter of Francis with the Leper (2 Celano 9)
Autor:
Cusato, Michael F., author
Publikováno v:
Ordo et Sanctitas: The Franciscan Spiritual Journey in Theology and Hagiography: Essays in Honor of J.A. Wayne Hellmann, O.F.M. Conv.. 15:66-89
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Merton Annual. 2017, Vol. 30, p117-130. 14p.
Autor:
OP Innocent Smith
Publikováno v:
Theological Studies. 79:782-800
Thomas Aquinas’ theology of mercy is deeply marked by the liturgical tradition of the Order of Preachers, incorporating many explicit and implicit references to liturgical prayers in praise of God’s mercy. This article explores the liturgical con
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Mercy Evanescent: Thomas of Celano’s Rewrite of the Encounter of Francis with the Leper (2 Celano 9)
Autor:
Michael F. Cusato
Publikováno v:
Ordo et Sanctitas: The Franciscan Spiritual Journey in Theology and Hagiography ISBN: 9789004335639
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61711b7118f53330152234bf493902e8
https://doi.org/10.1163/9789004341159_006
https://doi.org/10.1163/9789004341159_006
Autor:
Nour K. Majbour, Jan O. Aasly, Eldbjørg Hustad, Mercy A. Thomas, Nishant N. Vaikath, Naser Elkum, Wilma D. J. van de Berg, Takahiko Tokuda, Brit Mollenhauer, Henk W. Berendse, Omar M. A. El-Agnaf
Publikováno v:
Translational Neurodegeneration, Vol 9, Iss 1, Pp 1-10 (2020)
Abstract Background Asymptomatic carriers of leucine-rich repeat kinase 2 (LRRK2) gene mutations constitute an ideal population for discovering prodromal biomarkers of Parkinson’s disease (PD). In this study, we aim to identify CSF candidate risk b
Externí odkaz:
https://doaj.org/article/ee5ec5df964e4d5e95f941a5372ac1af
Autor:
Nour K, Majbour, Ilham Y, Abdi, Mohammed, Dakna, Tamara, Wicke, Elisabeth, Lang, Houda Y, Ali Moussa, Mercy A, Thomas, Claudia, Trenkwalder, Bared, Safieh-Garabedian, Takahiko, Tokuda, Brit, Mollenhauer, Omar, El-Agnaf
Publikováno v:
Movement disorders : official journal of the Movement Disorder SocietyReferences. 36(9)
Tangible efforts have been made to identify biomarkers for Parkinson's disease (PD) diagnosis and progression, with α-synuclein (α-syn) related biomarkers being at the forefront.The objectives of this study were to explore whether cerebrospinal flu
Autor:
Naser Elkum, Brit Mollenhauer, Nour K. Majbour, Henk W. Berendse, Nishant N. Vaikath, Jan O. Aasly, Wilma D.J. van de Berg, Eldbjørg Hustad, Mercy A. Thomas, Takahiko Tokuda, Omar M. A. El-Agnaf
Publikováno v:
Majbour, N K, Aasly, J O, Hustad, E, Thomas, M A, Vaikath, N N, Elkum, N, Van De Berg, W D J, Tokuda, T, Mollenhauer, B, Berendse, H W & El-Agnaf, O M A 2020, ' CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson's disease : A study in LRRK2 mutation carriers ', Translational Neurodegeneration, vol. 9, no. 1, 15 . https://doi.org/10.1186/s40035-020-00192-4
Translational Neurodegeneration, Vol 9, Iss 1, Pp 1-10 (2020)
Translational Neurodegeneration, 9(1):15. BioMed Central
Translational Neurodegeneration
Translational Neurodegeneration, Vol 9, Iss 1, Pp 1-10 (2020)
Translational Neurodegeneration, 9(1):15. BioMed Central
Translational Neurodegeneration
Background Asymptomatic carriers of leucine-rich repeat kinase 2 (LRRK2) gene mutations constitute an ideal population for discovering prodromal biomarkers of Parkinson’s disease (PD). In this study, we aim to identify CSF candidate risk biomarkers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7707e836bbab831860ddb0e45042e560
https://research.vumc.nl/en/publications/34a8932a-77db-4202-943a-4243e65b8ed7
https://research.vumc.nl/en/publications/34a8932a-77db-4202-943a-4243e65b8ed7
Autor:
Majbour, Nour K., Aasly, Jan O., Hustad, Eldbjørg, Mercy A. Thomas, Nishant N. Vaikath, Elkum, Naser, Berg, Wilma D. J. Van De, Tokuda, Takahiko, Mollenhauer, Brit, Berendse, Henk W., El-Agnaf, Omar M. A.
Additional file 1: Supplementary Table 1. Associations between CSF biomarkers. No correlation between CSF biomarkers were present in symptomatic LRRK2 mutation carriers group alone. Both sPD and symptomatic LRRK2 mutation carriers groups were combine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8faaa8886835f8880f015c635d6f207a